Praxis Precision Medicines
PRAX
#2556
Rank
A$10.23 B
Marketcap
A$409.26
Share price
9.27%
Change (1 day)
293.52%
Change (1 year)

Revenue for Praxis Precision Medicines (PRAX)

Revenue in 2025 (TTM): A$11.99 Million

According to Praxis Precision Medicines's latest financial reports the company's current revenue (TTM ) is A$11.27 Million. In 2024 the company made a revenue of A$13.75 Million an increase over the revenue in the year 2023 that were of A$3.59 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Praxis Precision Medicines from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) A$11.99 M-12.74%
2024 A$13.75 M282.85%
2023 A$3.59 M
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA